Corpus ID: 701598

Rediscovering Chirality - Role of S-Metoprolol in Cardiovascular Disease Management.

@article{Mohan2017RediscoveringC,
  title={Rediscovering Chirality - Role of S-Metoprolol in Cardiovascular Disease Management.},
  author={J. Mohan and S. Shah and Sunny Chinchansurkar and Arindam Dey and R. Jain},
  journal={The Journal of the Association of Physicians of India},
  year={2017},
  volume={65 6},
  pages={
          74-79Jagdish
        }
}
  • J. Mohan, S. Shah, +2 authors R. Jain
  • Published 2017
  • Medicine
  • The Journal of the Association of Physicians of India
BACKGROUND The process of drug discovery and development today encompass a myriad of paths for bringing a new therapeutic molecule that has minimal adverse effects and of optimal use to the patient. Chirality was proposed in the direction of providing a purer and safer form of drug [Ex- cetrizine and levocetrizine]. Decades have passed since the introduction of this concept and numerous chiral molecules are in existence in therapeutics, yet somehow this concept has been ignored. This review… Expand

References

SHOWING 1-10 OF 37 REFERENCES
Stereoisomers and Drug Toxicity
Pharmacology of chiral compounds: 2-arylpropionic acid derivatives.
...
1
2
3
4
...